Organisation
Neurology
Department
The service neurology focuses on the diagnosis and treatment of diseases of the nervous system (brain, spinal cord, spinal roots, nerves) and muscles.
Current researchers
31 - 37 of 37 results
- Evelien Tuerlinckx (Member)
- Arnaud Van Ingelghem (Member)
- Gilles Van Loock (Member)
- Jeroen Van Schependom (Member)
- Maxime Vande Vyver (Member)
- Fenne Vandervorst (Member)
- Jan Versijpt (Member)
Publications
1 - 10 of 349
- Correction(2017)
Authors: Isabel H Salas, Zsuzsanna Callaerts-Vegh, Amaia M Arranz, Francesc X Guix, Rudi D'Hooge, José A Esteban, Bart De Strooper, Carlos G Dotti
- Biomarkers voor de diagnostiek van de ziekte van Alzheimer
Authors: Sebastiaan Engelborghs
Pages: 13-17 - SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population
Authors: Karolien Bettens, Nathalie Brouwers, Sebastiaan Engelborghs, Peter De Deyn, C. Van Broeckhoven, Kristel Sleegers
Pages: 769-770 - GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population
Authors: Bram Meeus, Karen Nuytemans, David Crosiers, Sebastiaan Engelborghs, Philippe Pals, Barbara Pickut, Karin Peeters, Maria Mattheijssens, Ellen Corsmit, Patrick Cras, et al.
Pages: 308-312 - Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies
Authors: Sylvie Slaets, Nathalie Le Bastard, Jessie Theuns, Kristel Sleegers, Aline Verstraeten, Evelyn De Leenheir, Jill Luyckx, Jean-Jacques Martin, Christine Van Broeckhoven, Sebastiaan Engelborghs
Pages: 137-146 - The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter
Authors: I. Gijselinck, S. Van Mossevelde, J. Van Der Zee, A. Sieben, Sebastiaan Engelborghs, J. De Bleecker, Adrian Ivanoiu, Oliver Deryck, D. Edbauer, M. Zhang, et al.
Pages: 1112-1124 - DNMBP is genetically associated with Alzheimer dementia in the Belgian population
Authors: Karolien Bettens, Nathalie Brouwers, Sebastiaan Engelborghs, Tim De Pooter, Peter De Deyn, Kristel Sleegers, Christine Van Broeckhoven
Pages: 2000-2009 - Long-term safety and effectiveness of natalizumab treatment in clinical practice
Authors: Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl, Maria Trojano, Tim Spelman, Ih Chang, Rachna Kasliwal, Seema Jaitly, Nolan Campbell, Pei-Ran Ho, et al.
Pages: 660-668 - TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels(2021)
Authors: Shengjun Hong, Valerija Dobricic, Olena Ohlei, Isabelle Bos, Stephanie J B Vos, Dmitry Prokopenko, Betty M Tijms, Ulf Andreasson, Kaj Blennow, Rik Vandenberghe, et al.
Pages: 1628-1640 - A decade of cerebrospinal fluid biomarkers for Alzheimers disease in Belgium(2016)
Authors: Charisse Somers, Hanne Struyfs, Joery Goossens, Ellis Niemantsverdriet, Jill Luyckx, Naomi De Roeck, Ellen E De Roeck, Bart De Vil, Patrick Cras, Jean-Jacques Martin, et al.
Pages: 383-395